Tuberculosis 5 Global tuberculosis drug development pipeline: the need and the reality

Article de revue

Avec comité de lecture

ZHENKUN MA, Christian Lienhardt, Helen Mcllleron, Andrew J Nunn et XIEXIU Wang

The Lancet (British edition), Vol.375(9731), pp.2100-2109

12/06/2010

Résumé

Bacterial diseases

Biological and medical sciences

General aspects

Human bacterial diseases

Infectious diseases

Medical sciences

Tuberculosis and atypical mycobacterial infections

1 Consultations de la notice

Titre: Tuberculosis 5 Global tuberculosis drug development pipeline: the need and the reality
Créateurs - sans rôle: ZHENKUN MA - Global Alliance forTB Drug Development, NewYork, NY, United States
Christian Lienhardt - Stop TB Partnership Secretariat, Stop TB Department, WHO, Geneva, Switzerland
Helen Mcllleron - Division of Clinical Pharmacology, Department of Medicine, University ofCape Town, Cape Town, South Africa
Andrew J Nunn - Medical Research Council Clinical Trials Unit, London, United Kingdom
XIEXIU Wang - Tianjin Centres for Disease Control and Prevention, Tianjin, China
Détails de publication: The Lancet (British edition), Vol.375(9731), pp.2100-2109
Éditeur: Elsevier
Nombre de pages: 10
Identifiants: 99158574709311
Unité académique: Recherches translationnelles sur le VIH et les Maladies Infect. Endém. émerg. - TransVIHMI
Langue: English
Type de ressource: Journal article